NCT03915184: Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 105 planned
- Started
- 25 Sep 2019
- Primary completion
- 31 Dec 2024
- Arms
- CAR-BCMA T Cells
- Results
- None posted
- 16 Apr 2019: Trial registered
- 25 Sep 2019: Trial started